Related Experiment Video
Updated: Mar 14, 2026
High Throughput Sequential ELISA for Validation of Biomarkers of Acute Graft-Versus-Host Disease
Published on: October 31, 2012
Diagnostic potential of total serum ghrelin in autoimmune gastritis: A systematic review and meta-analysis
Iqbal Taufiqqurrachman1,2, Andro Pramana Witarto3,4, Ari Fahrial Syam5
1Department of Environmental and Preventive Medicine, Oita University Faculty of Medicine, Yufu, Japan.
Background:
Autoimmune gastritis (AIG) is a chronic inflammatory condition characterized by the destruction of gastric parietal cells. The invasive nature of diagnostic procedures and risk of confounding factors hinder the development of reliable diagnostic tools for AIG.
Methods:
We conducted a systematic search of four databases. After assessing the study quality using the ROBINS-E tool, a meta-analysis was performed using a random-effects model. Meta-regression and sensitivity analyses were conducted to explore the sources of heterogeneity and impact of study bias.
Results:
The pooled mean difference in total serum ghrelin (pmol/L) between patients with AIG and healthy controls was -65.28 (95% CI: -178.54, 47.97). Subgroup analysis showed that the mean differences in serum ghrelin for mild, moderate, and severe atrophy were -78.85 (95% CI: -165.17, to 7.48), -91.97 (95% CI: -183.11, to -0.84), and -110.67 (95% CI: -204.77, to -16.56), respectively. The sensitivity analysis confirmed that the exclusion of studies with high-risk bias did not significantly alter the results. Meta-regression indicated that BMI contributed substantially to heterogeneity.
Conclusions:
Although total serum ghrelin levels were not significantly different between patients with AIG and healthy controls, significantly lower levels were observed in patients with moderate-to-severe gastric atrophy. Given the high heterogeneity and limitations of existing studies, the diagnostic utility of serum ghrelin in AIG warrants further investigation.
More Related Videos
10:27Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
Published on: December 15, 2011
06:50A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases
Published on: May 29, 2020
Related Concept Videos
01:27Gastritis-I: Introduction and Types
Acute gastritis presents as a sudden inflammation triggered by various stressors to the stomach lining, such as exposure to corrosive agents, local irritants like aspirin and other NSAIDs, alcohol consumption, radiation therapy, physical trauma, severe burns, sepsis,...
01:23Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
01:17Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
01:15Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
01:30Serum Laboratory Studies, Stool Test, Breath Test